INTEGRA LIFESCIENCES HLDGS C's ticker is IART and the CUSIP is 457985208. A total of 259 filers reported holding INTEGRA LIFESCIENCES HLDGS C in Q1 2021. The put-call ratio across all filers is 0.98 and the average weighting 0.1%.
Quarter-by-quarter ownership
Value | Shares | Weighting | ||||
---|---|---|---|---|---|---|
Q1 2023 | $233,659 | +2.4% | 4,070 | 0.0% | 0.01% | 0.0% |
Q4 2022 | $228,205 | +3.7% | 4,070 | 0.0% | 0.01% | 0.0% |
Q2 2022 | $220,000 | -15.1% | 4,070 | +1.0% | 0.01% | 0.0% |
Q1 2022 | $259,000 | -4.1% | 4,030 | 0.0% | 0.01% | 0.0% |
Q4 2021 | $270,000 | -2.2% | 4,030 | 0.0% | 0.01% | -7.7% |
Q3 2021 | $276,000 | +0.4% | 4,030 | 0.0% | 0.01% | 0.0% |
Q2 2021 | $275,000 | -3.2% | 4,030 | -1.9% | 0.01% | -7.1% |
Q1 2021 | $284,000 | +6.4% | 4,110 | 0.0% | 0.01% | -6.7% |
Q4 2020 | $267,000 | +10.3% | 4,110 | -1.0% | 0.02% | +15.4% |
Q4 2019 | $242,000 | -9.4% | 4,150 | -6.7% | 0.01% | -18.8% |
Q3 2019 | $267,000 | +8.5% | 4,450 | +0.9% | 0.02% | +6.7% |
Q2 2019 | $246,000 | 0.0% | 4,410 | 0.0% | 0.02% | 0.0% |
Q1 2019 | $246,000 | -19.9% | 4,410 | -5.4% | 0.02% | -16.7% |
Q3 2018 | $307,000 | -1.6% | 4,660 | -3.9% | 0.02% | 0.0% |
Q2 2018 | $312,000 | +10.2% | 4,850 | -5.1% | 0.02% | 0.0% |
Q1 2018 | $283,000 | +1.1% | 5,110 | -12.6% | 0.02% | +12.5% |
Q4 2017 | $280,000 | -3.4% | 5,850 | +0.7% | 0.02% | -15.8% |
Q3 2017 | $290,000 | -7.3% | 5,810 | 0.0% | 0.02% | -5.0% |
Q2 2017 | $313,000 | +27.8% | 5,810 | 0.0% | 0.02% | +25.0% |
Q1 2017 | $245,000 | -1.6% | 5,810 | +100.0% | 0.02% | -5.9% |
Q4 2016 | $249,000 | -10.1% | 2,905 | -10.8% | 0.02% | -15.0% |
Q3 2016 | $277,000 | +2.6% | 3,255 | -3.8% | 0.02% | +5.3% |
Q2 2016 | $270,000 | +25.6% | 3,385 | +5.9% | 0.02% | +18.8% |
Q1 2016 | $215,000 | -0.5% | 3,195 | 0.0% | 0.02% | 0.0% |
Q4 2015 | $216,000 | +0.5% | 3,195 | 0.0% | 0.02% | +6.7% |
Q2 2015 | $215,000 | -20.7% | 3,195 | -27.2% | 0.02% | -21.1% |
Q1 2015 | $271,000 | -44.2% | 4,388 | -57.5% | 0.02% | -54.8% |
Q2 2014 | $486,000 | -29.2% | 10,317 | -30.8% | 0.04% | -33.3% |
Q1 2014 | $686,000 | -7.4% | 14,908 | -4.0% | 0.06% | -12.5% |
Q4 2013 | $741,000 | +16.1% | 15,535 | -1.9% | 0.07% | +1.4% |
Q3 2013 | $638,000 | +10.0% | 15,840 | 0.0% | 0.07% | -1.4% |
Q2 2013 | $580,000 | – | 15,840 | – | 0.07% | – |
Download |
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|---|---|---|
VeriStar Capital Management LP | 268,000 | $10,234,920 | 8.72% |
Madison Avenue Partners, LP | 964,667 | $36,840,633 | 5.23% |
Pavadi Capital LLC | 99,999 | $3,818,962 | 4.97% |
KESTREL INVESTMENT MANAGEMENT CORP | 122,450 | $4,676 | 2.96% |
Sapience Investments, LLC | 245,700 | $9,383,283 | 2.26% |
Ellsworth Advisors, LLC | 102,500 | $3,882,700 | 1.38% |
Point72 Europe (London) LLP | 464,462 | $17,737,804 | 1.09% |
COOKE & BIELER LP | 2,714,194 | $103,655,069 | 1.01% |
TANDEM CAPITAL MANAGEMENT CORP /ADV | 75,586 | $2,886,630 | 0.99% |
DEERFIELD MANAGEMENT COMPANY, L.P. (SERIES C) | 1,126,827 | $43,033,523 | 0.95% |